Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Ran Xu

Jian Li

Shuhui Chen

Yuan Chen

Bin Chen

Yuanshan Yao

Chengshuai Yang

Hongwei Li

Ao Qiong Li

Dongdong Tian

Feng Gao

Zhensheng Huang

Sheng Zhang

Provided are a tricyclic compound as shown in formula (I) as a CRTH2 inhibitor, or a pharmaceutically acceptable salt, a tautomer, a stereoisomer or a solvate thereof, and the use thereof in treating diseases related to CRTH2 receptors. 

Tricyclic compound as CRTH2 inhibitor

Disclosed are a crystal form of an indole derivative (compound 1) and a pharmaceutical composition and preparation method thereof. The crystal form is used to prepare a drug for treating a disease related to a CRTH2 receptor. 

Crystal form of indole derivative and preparation method and use thereof

The present application discloses an indole as represented by formula (I) used as a CRTH2 inhibitor, and a pharmaceutically acceptable salt or tautomer of the indole, and an application of same in treating a disease related to a CRTH2 receptor. 

Indole derivative used as CRTH2 inhibitor

Growing community of inventors

Shanghai, China

Ran Xu